IMCEPSEO
Live / Registered — Registered (as of 09 Apr 2024)
What this means for you
Registered since 09 Apr 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 09 Apr 2030: the §8 declaration of use).
Record
- Serial number
- 97408975
- Registration number
- 7350179
- Mark type
- Word mark
- Filed
- 13 May 2022
- Published for opposition
- 11 Jul 2023
- Registered
- 09 Apr 2024
- Next maintenance filing
- §8 declaration of use, due by 09 Apr 2030 (grace period to 09 Oct 2030)
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prosecution history
- 09 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Mar 2024 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 08 Jan 2024 — NOTICE OF ALLOWANCE CANCELLED
- 01 Mar 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Jan 2024 — TEAS DELETE 1(B) BASIS RECEIVED
- 05 Sept 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Jul 2023 — PUBLISHED FOR OPPOSITION
- 21 Jun 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Jun 2023 — ELECTRONIC RECORD REVIEW COMPLETE
- 02 Jun 2023 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 26 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE